The U.S. Centers for Medicare & Medicaid Services is proposing a change to the Medicare disproportionate share hospital (DSH) payment methodology that could cause some hospitals in seven states to be disqualified from the 340B program.
The U.S. Centers for Medicare & Medicaid Services (CMS) has proposed to delay implementing a portion of a regulation encouraging value-based purchasing for drugs in the Medicaid program that may lead to drugs having multiple best prices.
Community Voices for 340B (CV340B), the first non-profit grassroots organization focused on promoting the importance of the 340B program, kicked off the first of series of regional educational webinars scheduled last week. The event, which was focused on the Northeast …
While an important drug’s introduction into the generic market is often celebrated by both providers and patients, generic pre-exposure prophylaxis drugs (PrEP) for patients at risk of contracting HIV could prove a financial disaster for some 340B covered entities. …
A U.S. House committee alleged Tuesday that AbbVie gamed the federal orphan drug program to boost profits for its anti-inflammatory drug Humira—by far, the top-selling medicine in the United States. …
Please Login or Become a Paid
Montana has passed a law barring pharmacy benefit managers (PBMs) from excluding 340B contract pharmacies from participating in their networks.
HHS has asked the U.S. Supreme Court to decline taking up 340B hospital suit on Medicare Part B reimbursement.
Rep. Doris Matsui (D-CA) has reintroduced a bill to protect 340B hospitals from losing eligibility during COVID-19.
Andrea Palm, the new HHS deputy secretary, was often the person 340B stakeholders met with at HHS when she served in the department during the Obama administration.
Rep. Elise Stefanik (R-N.Y.), one of the 340B program’s most vocal advocates in the U.S. House, is expected to be elevated to the House GOP's No. 3 leadership post. | C-SPAN
While 340B hospitals eagerly await to see the Biden administration’s plans for Medicare Part B reimbursement, the U.S. Department of Health and Human Services (HHS) last night asked the U.S. Supreme Court to reject an effort by hospital groups to …
A bipartisan group of six U.S. House members, led by Rep. Doris Matsui (D-CA), have re-introduced a bill that would prevent hospitals from losing eligibility for 340B discounts as a result of the COVID-19 pandemic. …
Please
The U.S. Senate on Wednesday voted 61-37 to confirm Andrea Palm’s nomination to be deputy secretary for the U.S. Department of Health and Human Services (HHS). Palm voiced support for the 340B program during her confirmation hearing.
There is a 340B angle in the fight in the U.S. House over who should be third in the Republican leadership ranks.